[Chronic myeloid leukemia]

Dtsch Med Wochenschr. 2011 Oct;136(40):2007-10. doi: 10.1055/s-0031-1286381. Epub 2011 Sep 28.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzamides
  • DNA Mutational Analysis
  • Dose-Response Relationship, Drug
  • Genes, abl / genetics
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Imatinib Mesylate
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Neoplasm, Residual / drug therapy
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Prognosis
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Benzamides
  • Interferon-alpha
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases